Predictors of 1-y NRM
. | Univariate . | Multivariate . | |||||
---|---|---|---|---|---|---|---|
Characteristics . | Adults, n (%) N = 585 . | HR . | 95% CI . | P . | HR . | 95% CI . | P . |
Toxicity (time dependent) | 38 | 4.9 | 2.7-8.6 | <.001 | 5.7 | 3.1-10.5 | <.001 |
Age, y Age >55 Age ≤55 | 309 (53) 276 (47) | 1.3 1.0 | 0.9-2.1 | .2 | — | — | — |
Disease status Active Remission | 356 61) 229 (39) | 1.6 1.0 | 0.9-2.5 | .05 | — | — | — |
GVHD prophylaxis PTCy-based Non-PTCy | 272 (46) 313 (53) | 0.4 1.0 | 0.2-0.7 | <.001 | 0.4 | 0.2-0.6 | <.001 |
Preparative regimen Reduced intensity Myeloablative | 201 (34) 384 (66) | 1.5 1.0 | 0.9-2.3 | .05 | — | — | — |
Stem cell source Peripheral blood Bone marrow | 475 (81) 110 (19) | 0.6 1.0 | 0.4-1.0 | .06 | — | — | — |
History of HTN Yes No | 235 (40) 350 (60) | 1.6 1.0 | 1.1-2.5 | .02 | — | — | — |
History of hyperlipidemia Yes No | 115 (20) 470 (80) | 0.9 1.0 | 0.5-1.6 | .7 | — | — | — |
Smoker Yes No | 227 (39) 356 (61) | 1.6 1.0 | 1.05-2.4 | .03 | 1.6 | 1.03-2.4 | .04 |
KPS <90 ≥90 | 230 (39) 287 (49) | 1.5 1.0 | 0.9-2.3 | .1 | — | — | — |
HCT-CI | |||||||
>3 | 195 (33) | 2.8 | 1.8-4.3 | <.001 | 2.6 | 1.7-4.1 | <.001 |
≤3 | 390 (67) | 1.0 | — | — | — | — | — |
. | Univariate . | Multivariate . | |||||
---|---|---|---|---|---|---|---|
Characteristics . | Adults, n (%) N = 585 . | HR . | 95% CI . | P . | HR . | 95% CI . | P . |
Toxicity (time dependent) | 38 | 4.9 | 2.7-8.6 | <.001 | 5.7 | 3.1-10.5 | <.001 |
Age, y Age >55 Age ≤55 | 309 (53) 276 (47) | 1.3 1.0 | 0.9-2.1 | .2 | — | — | — |
Disease status Active Remission | 356 61) 229 (39) | 1.6 1.0 | 0.9-2.5 | .05 | — | — | — |
GVHD prophylaxis PTCy-based Non-PTCy | 272 (46) 313 (53) | 0.4 1.0 | 0.2-0.7 | <.001 | 0.4 | 0.2-0.6 | <.001 |
Preparative regimen Reduced intensity Myeloablative | 201 (34) 384 (66) | 1.5 1.0 | 0.9-2.3 | .05 | — | — | — |
Stem cell source Peripheral blood Bone marrow | 475 (81) 110 (19) | 0.6 1.0 | 0.4-1.0 | .06 | — | — | — |
History of HTN Yes No | 235 (40) 350 (60) | 1.6 1.0 | 1.1-2.5 | .02 | — | — | — |
History of hyperlipidemia Yes No | 115 (20) 470 (80) | 0.9 1.0 | 0.5-1.6 | .7 | — | — | — |
Smoker Yes No | 227 (39) 356 (61) | 1.6 1.0 | 1.05-2.4 | .03 | 1.6 | 1.03-2.4 | .04 |
KPS <90 ≥90 | 230 (39) 287 (49) | 1.5 1.0 | 0.9-2.3 | .1 | — | — | — |
HCT-CI | |||||||
>3 | 195 (33) | 2.8 | 1.8-4.3 | <.001 | 2.6 | 1.7-4.1 | <.001 |
≤3 | 390 (67) | 1.0 | — | — | — | — | — |